SPRO - Spero Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Spero Therapeutics's activity chart (see below) currently has 21 price targets and 21 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.52% with an average time for these price targets to be met of 41 days.

Most recent stock forecast was given by from HC WAINWRIGHT on 30-Jan-2025.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-May-2020

$5

1 years 7 months 10 days ago
(30-Jan-2025)

0/15 (0%)

$3.87 (342.48%)

0

Hold Since 20-Dec-2024

1 years 8 months 20 days ago
(20-Dec-2024)

1/2 (50%)

$5.8 (263.64%)

3

13.52

Buy Since 09-Feb-2018

1 years 9 months 25 days ago
(15-Nov-2024)

0/5 (0%)

$3.35 (203.03%)

0

Buy Since 20-May-2022

$2

$-0.67 (-25.09%)

$31

4 years 3 months 20 days ago
(20-May-2022)

1/2 (50%)

$0.62 (44.93%)

125

Buy Since 02-Oct-2019

$20

4 years 11 months 7 days ago
(02-Oct-2021)

2/3 (66.67%)

$3.26 (19.47%)

241

Show more analysts

Please expand the browser size to see the chart

What is SPRO (Spero Therapeutics) average time for price targets to be met?

On average it took 41 days for the stock forecasts to be reached, with an average price target met ratio of 18.52%.

Which analyst most recently updated their price target on SPRO (Spero Therapeutics)?

Which analyst has the most public recommendations on SPRO (Spero Therapeutics)?

has 0 price targets and 0 ratings on SPRO

Which analyst is the currently most bullish on SPRO (Spero Therapeutics)?

Ed Arce with the highest potential upside of $24.33

Which analyst is the currently most reserved on SPRO (Spero Therapeutics)?

Esther Hong with the lowest potential downside of -$0.67

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?